Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
Interest Income Expense
Meridian Bioscience Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Meridian Bioscience Inc
NASDAQ:VIVO
|
Interest Income Expense
-$1.2m
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Interest Income Expense
-$118.3m
|
CAGR 3-Years
-81%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-30%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Interest Income Expense
-$86m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-17%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Interest Income Expense
$19.3m
|
CAGR 3-Years
93%
|
CAGR 5-Years
18%
|
CAGR 10-Years
39%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Interest Income Expense
$5.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Meridian Bioscience Inc's Interest Income Expense?
Interest Income Expense
-1.2m
USD
Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Interest Income Expense amounts to -1.2m USD.
What is Meridian Bioscience Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
5%
Over the last year, the Interest Income Expense growth was 38%. The average annual Interest Income Expense growth rates for Meridian Bioscience Inc have been 2% over the past three years , 5% over the past five years .